Does USTEKINUMAB Cause Foot deformity? 558 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 558 reports of Foot deformity have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.7% of all adverse event reports for USTEKINUMAB.
558
Reports of Foot deformity with USTEKINUMAB
0.7%
of all USTEKINUMAB reports
327
Deaths
245
Hospitalizations
How Dangerous Is Foot deformity From USTEKINUMAB?
Of the 558 reports, 327 (58.6%) resulted in death, 245 (43.9%) required hospitalization, and 235 (42.1%) were considered life-threatening.
Is Foot deformity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 558 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Foot deformity?
ADALIMUMAB (2,799)
ETANERCEPT (1,851)
METHOTREXATE (1,791)
ABATACEPT (1,218)
TOFACITINIB (1,156)
RITUXIMAB (1,147)
TOCILIZUMAB (1,134)
LEFLUNOMIDE (1,117)
CERTOLIZUMAB PEGOL (945)
GOLIMUMAB (927)
Which USTEKINUMAB Alternatives Have Lower Foot deformity Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE